linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Aurobindo Pharma Ltd.
 
Source DateBoard Meeting DateDetails
30 Jan 202609 Feb 2026 Quarterly Results
24 Oct 202505 Nov 2025 Quarterly Results
23 Jul 202504 Aug 2025 Interim Dividend & Quarterly Results
16 May 202526 May 2025 Audited Results
17 Jan 202506 Feb 2025 Quarterly Results
04 Nov 202409 Nov 2024 Quarterly Results
31 Jul 202410 Aug 2024 Quarterly Results
15 Jul 202418 Jul 2024 Buy Back of Shares
16 May 202425 May 2024 Audited Results
01 Feb 202410 Feb 2024 Interim Dividend
27 Oct 202309 Nov 2023 Interim Dividend & Quarterly Results
03 Aug 202312 Aug 2023 Quarterly Results
18 May 202327 May 2023 Audited Results
31 Jan 202309 Feb 2023 Quarterly Results & Interim Dividend
31 Oct 202212 Nov 2022 Quarterly Results
03 Aug 202211 Aug 2022 Quarterly Results
20 May 202230 May 2022 Audited Results & Fourth Interim Dividend
31 Jan 202209 Feb 2022 Third Interim Dividend & Quarterly Results
01 Nov 202108 Nov 2021 Quarterly Results & Second Interim Dividend
04 Aug 202112 Aug 2021 Interim Dividend & Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.